UniProt ID | HIPK3_HUMAN | |
---|---|---|
UniProt AC | Q9H422 | |
Protein Name | Homeodomain-interacting protein kinase 3 | |
Gene Name | HIPK3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1215 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Serine/threonine-protein kinase involved in transcription regulation, apoptosis and steroidogenic gene expression. Phosphorylates JUN and RUNX2. Seems to negatively regulate apoptosis by promoting FADD phosphorylation. Enhances androgen receptor-mediated transcription. May act as a transcriptional corepressor for NK homeodomain transcription factors. The phosphorylation of NR5A1 activates SF1 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation. In osteoblasts, supports transcription activation: phosphorylates RUNX2 that synergizes with SPEN/MINT to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE).. | |
Protein Sequence | MASQVLVYPPYVYQTQSSAFCSVKKLKVEPSSCVFQERNYPRTYVNGRNFGNSHPPTKGSAFQTKIPFNRPRGHNFSLQTSAVVLKNTAGATKVIAAQAQQAHVQAPQIGAWRNRLHFLEGPQRCGLKRKSEELDNHSSAMQIVDELSILPAMLQTNMGNPVTVVTATTGSKQNCTTGEGDYQLVQHEVLCSMKNTYEVLDFLGRGTFGQVVKCWKRGTNEIVAIKILKNHPSYARQGQIEVSILARLSTENADEYNFVRAYECFQHRNHTCLVFEMLEQNLYDFLKQNKFSPLPLKVIRPILQQVATALKKLKSLGLIHADLKPENIMLVDPVRQPYRVKVIDFGSASHVSKTVCSTYLQSRYYRAPEIILGLPFCEAIDMWSLGCVIAELFLGWPLYPGALEYDQIRYISQTQGLPGEQLLNVGTKSTRFFCKETDMSHSGWRLKTLEEHEAETGMKSKEARKYIFNSLDDVAHVNTVMDLEGSDLLAEKADRREFVSLLKKMLLIDADLRITPAETLNHPFVNMKHLLDFPHSNHVKSCFHIMDICKSHLNSCDTNNHNKTSLLRPVASSSTATLTANFTKIGTLRSQALTTSAHSVVHHGIPLQAGTAQFGCGDAFQQTLIICPPAIQGIPATHGKPTSYSIRVDNTVPLVTQAPAVQPLQIRPGVLSQTWSGRTQQMLVPAWQQVTPLAPATTTLTSESVAGSHRLGDWGKMISCSNHYNSVMPQPLLTNQITLSAPQPVSVGIAHVVWPQPATTKKNKQCQNRGILVKLMEWEPGREEINAFSWSNSLQNTNIPHSAFISPKIINGKDVEEVSCIETQDNQNSEGEARNCCETSIRQDSDSSVSDKQRQTIIIADSPSPAVSVITISSDTDEEETSQRHSLRECKGSLDCEACQSTLNIDRMCSLSSPDSTLSTSSSGQSSPSPCKRPNSMSDEEQESSCDTVDGSPTSDSSGHDSPFAESTFVEDTHENTELVSSADTETKPAVCSVVVPPVELENGLNADEHMANTDSICQPLIKGRSAPGRLNQPSAVGTRQQKLTSAFQQQHLNFSQVQHFGSGHQEWNGNFGHRRQQAYIPTSVTSNPFTLSHGSPNHTAVHAHLAGNTHLGGQPTLLPYPSSATLSSAAPVAHLLASPCTSRPMLQHPTYNISHPSGIVHQVPVGLNPRLLPSPTIHQTQYKPIFPPHSYIAASPAYTGFPLSPTKLSQYPYM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MASQVLVYPPYVYQT CCCEEEECCCCEEEC | 8.37 | - | |
27 | Sumoylation | FCSVKKLKVEPSSCV CCCEEECEECCHHCE | 54.13 | - | |
27 | Sumoylation | FCSVKKLKVEPSSCV CCCEEECEECCHHCE | 54.13 | 28112733 | |
58 | Ubiquitination | GNSHPPTKGSAFQTK CCCCCCCCCCCEECC | 57.55 | - | |
131 | Phosphorylation | RCGLKRKSEELDNHS CCCCCCCHHHHCCCC | 40.09 | 24043423 | |
138 | Phosphorylation | SEELDNHSSAMQIVD HHHHCCCCHHHHHHH | 26.50 | 24043423 | |
139 | Phosphorylation | EELDNHSSAMQIVDE HHHCCCCHHHHHHHH | 21.87 | 24043423 | |
148 | Phosphorylation | MQIVDELSILPAMLQ HHHHHHHCHHHHHHH | 21.74 | 24043423 | |
156 | Phosphorylation | ILPAMLQTNMGNPVT HHHHHHHHCCCCCEE | 24.18 | 24043423 | |
163 | Phosphorylation | TNMGNPVTVVTATTG HCCCCCEEEEEECCC | 15.54 | 24043423 | |
166 | Phosphorylation | GNPVTVVTATTGSKQ CCCEEEEEECCCCCC | 17.60 | 24043423 | |
168 | Phosphorylation | PVTVVTATTGSKQNC CEEEEEECCCCCCCC | 23.48 | 24043423 | |
169 | Phosphorylation | VTVVTATTGSKQNCT EEEEEECCCCCCCCC | 36.67 | 24043423 | |
171 | Phosphorylation | VVTATTGSKQNCTTG EEEECCCCCCCCCCC | 29.04 | 24043423 | |
219 | Phosphorylation | VKCWKRGTNEIVAIK HHHHHCCCCCEEEEE | 33.44 | - | |
226 | Ubiquitination | TNEIVAIKILKNHPS CCCEEEEEEHHCCHH | 32.04 | - | |
229 | Ubiquitination | IVAIKILKNHPSYAR EEEEEEHHCCHHHHH | 57.60 | - | |
292 | Phosphorylation | FLKQNKFSPLPLKVI HHHCCCCCCCCHHHH | 27.43 | 20068231 | |
324 | Ubiquitination | GLIHADLKPENIMLV CCEECCCCHHHEEEE | 51.32 | - | |
341 | Ubiquitination | VRQPYRVKVIDFGSA CCCCEEEEEEECCCC | 25.19 | - | |
353 | Ubiquitination | GSASHVSKTVCSTYL CCCCCCCHHHHHHHH | 43.84 | - | |
354 | Phosphorylation | SASHVSKTVCSTYLQ CCCCCCHHHHHHHHH | 21.16 | 23403867 | |
357 | Phosphorylation | HVSKTVCSTYLQSRY CCCHHHHHHHHHHCC | 18.75 | 23927012 | |
358 | Phosphorylation | VSKTVCSTYLQSRYY CCHHHHHHHHHHCCC | 24.11 | 23927012 | |
359 | Phosphorylation | SKTVCSTYLQSRYYR CHHHHHHHHHHCCCC | 6.10 | 23927012 | |
359 (in isoform 2) | Phosphorylation | - | 6.10 | 24719451 | |
362 | Phosphorylation | VCSTYLQSRYYRAPE HHHHHHHHCCCCCCH | 21.47 | 23927012 | |
365 | Phosphorylation | TYLQSRYYRAPEIIL HHHHHCCCCCCHHHH | 10.13 | 22817900 | |
428 (in isoform 1) | Ubiquitination | - | 43.85 | 21906983 | |
428 | Ubiquitination | QLLNVGTKSTRFFCK HEEECCCCCCEEEEE | 43.85 | 21906983 | |
428 (in isoform 2) | Ubiquitination | - | 43.85 | 21906983 | |
435 | Ubiquitination | KSTRFFCKETDMSHS CCCEEEEECCCCCCC | 59.50 | - | |
447 | Ubiquitination | SHSGWRLKTLEEHEA CCCCEEEEEHHHHHH | 42.35 | - | |
459 (in isoform 1) | Ubiquitination | - | 60.77 | 21906983 | |
459 | Ubiquitination | HEAETGMKSKEARKY HHHHHCCCCHHHHHH | 60.77 | 2190698 | |
459 (in isoform 2) | Ubiquitination | - | 60.77 | 21906983 | |
461 | Ubiquitination | AETGMKSKEARKYIF HHHCCCCHHHHHHHH | 50.29 | - | |
466 | Phosphorylation | KSKEARKYIFNSLDD CCHHHHHHHHHCHHH | 12.75 | - | |
492 | Ubiquitination | GSDLLAEKADRREFV CCHHHHHHCCHHHHH | 50.40 | - | |
500 | Phosphorylation | ADRREFVSLLKKMLL CCHHHHHHHHHHHHH | 33.05 | 24719451 | |
503 | Ubiquitination | REFVSLLKKMLLIDA HHHHHHHHHHHHHCC | 41.24 | - | |
504 | Ubiquitination | EFVSLLKKMLLIDAD HHHHHHHHHHHHCCC | 34.45 | - | |
515 (in isoform 2) | Phosphorylation | - | 15.26 | 24719451 | |
515 | Phosphorylation | IDADLRITPAETLNH HCCCCCCCCHHHHCC | 15.26 | 24719451 | |
519 (in isoform 2) | Phosphorylation | - | 34.66 | 24719451 | |
519 | Phosphorylation | LRITPAETLNHPFVN CCCCCHHHHCCCCCC | 34.66 | 24719451 | |
528 | Methylation | NHPFVNMKHLLDFPH CCCCCCHHHHHCCCC | 26.37 | 115970639 | |
528 | Ubiquitination | NHPFVNMKHLLDFPH CCCCCCHHHHHCCCC | 26.37 | - | |
563 | Ubiquitination | CDTNNHNKTSLLRPV CCCCCCCCCCCCEEE | 31.75 | - | |
565 | Phosphorylation | TNNHNKTSLLRPVAS CCCCCCCCCCEEECC | 27.32 | 24719451 | |
565 (in isoform 2) | Phosphorylation | - | 27.32 | 24719451 | |
645 | Phosphorylation | HGKPTSYSIRVDNTV CCCCCEEEEEECCCE | 12.04 | 24719451 | |
772 (in isoform 2) | Phosphorylation | - | 2.86 | 24719451 | |
791 | Phosphorylation | EINAFSWSNSLQNTN HCCEEECCCCCCCCC | 18.49 | 26437602 | |
793 | Phosphorylation | NAFSWSNSLQNTNIP CEEECCCCCCCCCCC | 26.30 | 29802988 | |
802 | Phosphorylation | QNTNIPHSAFISPKI CCCCCCCCCEECCEE | 21.37 | 25690035 | |
806 | Phosphorylation | IPHSAFISPKIINGK CCCCCEECCEEECCC | 17.43 | 25627689 | |
813 | Ubiquitination | SPKIINGKDVEEVSC CCEEECCCCCEEEEE | 54.86 | - | |
852 | Ubiquitination | SDSSVSDKQRQTIII CCCCCCHHHCCEEEE | 39.61 | - | |
891 | Ubiquitination | RHSLRECKGSLDCEA HHHHHHCCCCCCHHH | 46.94 | - | |
893 | Phosphorylation | SLRECKGSLDCEACQ HHHHCCCCCCHHHHH | 13.41 | 28348404 | |
944 | Phosphorylation | MSDEEQESSCDTVDG CCHHHHHHCCCCCCC | 35.64 | 22468782 | |
952 | Phosphorylation | SCDTVDGSPTSDSSG CCCCCCCCCCCCCCC | 22.12 | 22468782 | |
1191 | Phosphorylation | KPIFPPHSYIAASPA CCCCCCCCEEECCCC | 24.82 | 22210691 | |
1200 | Phosphorylation | IAASPAYTGFPLSPT EECCCCCCCCCCCCC | 34.16 | 22210691 | |
1205 | Phosphorylation | AYTGFPLSPTKLSQY CCCCCCCCCCCHHHC | 30.66 | 26074081 | |
1207 | Phosphorylation | TGFPLSPTKLSQYPY CCCCCCCCCHHHCCC | 41.04 | 26074081 | |
1214 | Phosphorylation | TKLSQYPYM------ CCHHHCCCC------ | 15.55 | 22210691 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HIPK3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HIPK3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HIPK3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
P73_HUMAN | TP73 | physical | 10961991 | |
P53_HUMAN | TP53 | physical | 10961991 | |
SUMO1_HUMAN | SUMO1 | physical | 10961991 | |
TNR6_HUMAN | FAS | physical | 11034606 | |
FADD_HUMAN | FADD | physical | 11034606 | |
TRA2B_HUMAN | TRA2B | physical | 16000324 | |
SRSF5_HUMAN | SRSF5 | physical | 16000324 | |
ROA1_HUMAN | HNRNPA1 | physical | 16000324 | |
ROA2_HUMAN | HNRNPA2B1 | physical | 16000324 | |
HNRH1_HUMAN | HNRNPH1 | physical | 16000324 | |
SRSF1_HUMAN | SRSF1 | physical | 16000324 | |
SIAH2_HUMAN | SIAH2 | physical | 15231748 | |
TGFI1_HUMAN | TGFB1I1 | physical | 15231748 | |
TOX4_HUMAN | TOX4 | physical | 15231748 | |
C1QA_HUMAN | C1QA | physical | 15231748 | |
COT2_HUMAN | NR2F2 | physical | 15231748 | |
ARRB2_HUMAN | ARRB2 | physical | 15231748 | |
LIMK2_HUMAN | LIMK2 | physical | 15231748 | |
ZYX_HUMAN | ZYX | physical | 15231748 | |
LIMS2_HUMAN | LIMS2 | physical | 15231748 | |
SIAH1_HUMAN | SIAH1 | physical | 15231748 | |
GORS1_HUMAN | GORASP1 | physical | 15231748 | |
HEYL_HUMAN | HEYL | physical | 15231748 | |
MTMR4_HUMAN | MTMR4 | physical | 15231748 | |
LIMD1_HUMAN | LIMD1 | physical | 15231748 | |
ZN107_HUMAN | ZNF107 | physical | 15231748 | |
P53_HUMAN | TP53 | physical | 23602568 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-359, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-359, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-359, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-359, AND MASSSPECTROMETRY. |